Injectable dual glucose-responsive hydrogel-micelle composite for mimicking physiological basal and prandial insulin delivery

• 来源期刊: 中国科学:化学（英文版）
• 年，卷（期）: 2019,（5）
• 页码范围: 637-648
• 页数: 12页
• 语种: 英文

摘要

For type 1 and advanced type 2 diabetic patients,insulin replacement therapy with simulating on-demand prandial and basal insulin secretion is the best option for optimal glycemic control.However,there is no insulin delivery system yet could mimic both controlled basal insulin release and rapid prandial insulin release in response to real-time blood glucose changes.Here we reported an artificial insulin delivery system,mimicking physiological basal and prandial insulin secretion,to achieve real-time glycemic control and reduce risk of hypoglycemia.A phenylboronic acid (PBA)/galactosyl-based glucose-responsive insulin delivery system was prepared with insulin-loaded micelles embedded in hydrogel matrix.At the hyperglycemic state,both the hydrogel and micelles could swell and achieve rapid glucose-responsive release of insulin,mimicking prandial insulin secretion.When the glucose level returned to the normal state,only the micelles partially responded to glucose and still released insulin gradually.The hydrogel with increased crosslinking density could slow down the diffusion speed of insulin inside,resulting in controlled release of insulin and simulating physiological basal insulin secretion.This hydrogel-micelle composite insulin delivery system could quickly reduce the blood glucose level in a mouse model of type 1 diabetes,and maintain normal blood glucose level without hypoglycemia for about 24 h.This kind of glucose-responsive hydrogel-micelle composite may be a promising candidate for delivery of insulin in the treatment of diabetes.